




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Cardiac Surgery and Arrhythmias</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=bec15588-b83f-48f6-b6e7-acf0671bae3e</link>
        <description>Clinical Topic Feed: Cardiac Surgery and Arrhythmias</description>
        <language>en</language>

        

                <item>
                    <title>Eagle&#226;€™s Eye View: SPECIAL TCT RECAP focusing on four studies: PROGRESS on TAVR &amp; AS; SIMPLAFFY on NOACS &amp; DAPT; SPYRAL AFFIRM on RDN &amp; BP; IRIS MAIN on PCI &amp; CABG </title>
<link>/Latest-in-Cardiology/Articles/2026/11/05/17/14/eagles-eye-view-05nov2026</link>                    <description>In this special edition of the View, Dr. Eagle&#226;€&#175;looks at four studies presented at the recent TCT Conference that could have immediate effects on your practice.</description>
                    <pubdate>1793899080000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>TCT 2026 Science Published in the JACC Journals</title>
<link>/Latest-in-Cardiology/Articles/2026/10/26/16/55/sat-jacc-tct-2026</link>                    <description>Key research from TCT 2026 was simultaneously published across the JACC Journals, providing new findings across the spectrum of interventional cardiology. Explore highlights from nine studies...</description>
                    <pubdate>1793463840000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View: Sex Disparities in CV Trials; Left Stellate Ganglion Blocks &amp; CABG; Bifurcation Lesions; Managing Resistant Hypertension</title>
<link>/Latest-in-Cardiology/Articles/2026/10/14/12/36/eagles-eye-view-14oct2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle&#226;€&#175;looks at continued sex disparities in CV clinical trials.&#226;€&#175;He then examines how preemptive left stellate ganglion block (SGB) is associated with a reduced incidence of postoperative atrial fibrillation (POAF) in patients undergoing CABG.</description>
                    <pubdate>1791994020000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Racial, Ethnic and Place-Based Disparities in CVD Mortality in the US</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/10/05/20/22/Racial-Ethnic-and-Place-Based-Disparities-in-CVD-Mortality</link>                    <description>Despite sustained declines in overall cardiovascular disease mortality in the U.S., racial, ethnic and place-based disparities persist, with mortality varying far more across counties than states, according to a county-by-cause-by-population analysis published in JACC.</description>
                    <pubdate>1791383400000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Stellate Ganglion Block Reduces POAF After CABG</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/10/05/20/22/Stellate-Ganglion-Block</link>                    <description>Preemptive left stellate ganglion block (SGB) was associated with a reduced incidence of postoperative atrial fibrillation (POAF) within five postoperative days in patients undergoing CABG with cardiopulmonary bypass, according to results from a prospective controlled trial published Sept. 29 in JACC: Clinical Electrophysiology.</description>
                    <pubdate>1791378000000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Online Exclusive | NCDR: Driving Discovery. Improving CV Care</title>
<link>/Latest-in-Cardiology/Articles/2026/10/01/01/Online-Exclusive-NCDR</link>                    <description>ACC&#39;s NCDR suite of registries turns real-world clinical data into actionable insights that help hospitals, practices and clinicians advance the quality of cardiovascular care. From informing research to identifying opportunities for improvement,</description>
                    <pubdate>1790856720000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View: Top Trials from ESC 26</title>
<link>/Latest-in-Cardiology/Articles/2026/09/09/13/47/eagles-eye-view-09sep2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle&#226;€&#175;looks at some of the important trials presented at this year&#226;€™s European Society of Cardiology (ESC) Congress.</description>
                    <pubdate>1788961680000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Journal Wrap | Lifestyle Intervention Effective in Prediabetes; Aficamten Tops Metoprolol For Exercise in oHCM; More</title>
<link>/Latest-in-Cardiology/Articles/2026/09/01/01/Journal-Wrap</link>                    <description>The hottest research from various peer-reviewed journals &#226;€“ handpicked weekly by the ACC.</description>
                    <pubdate>1788264540000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Fifth Universal Definition of Myocardial Infarction (2026)</title>
<link>https://www.jacc.org/doi/10.1016/j.jacc.2026.07.025</link>                    <description></description>
                    <pubdate>1787913000000</pubdate>
                    <category>Guidelines</category>
                </item>
                <item>
                    <title>MERCURI-2: Dapagliflozin Before Cardiac Surgery Lowers Postoperative AKI Risk</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/08/10/15/19/MERCURI-2</link>                    <description>Starting dapagliflozin one day before elective cardiac surgery reduced the incidence of postoperative acute kidney injury (AKI) during the first seven days after surgery, according to results from the double-blind, placebo-controlled MERCURI-2 trial published July 30 in JAMA.</description>
                    <pubdate>1786471800000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>